What is the shelf life of physician-mixed antibiotic-impregnated calcium sulfate pellets?

Journal of Foot and Ankle Surgery

Volumn 42, Issue 5, 2003, Pages 302-304

  Armstrong, David G ^a,b   Stephan, Kevin T ^c   Espensen, Eric H ^d   Lipsky, Benjamin A ^e,f   Boulton, Andrew J M ^b  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c WILFORD HALL MEDICAL CENTER   (United States)

^d Providence Saint Joseph Medical Center   (United States)

^e VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic resistance; Antibiotics; Diabetes mellitus; Foot infection

Indexed keywords

CALCIUM SULFATE; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DIABETIC FOOT; DRUG FORMULATION; DRUG STABILITY; GROWTH INHIBITION; NONHUMAN; PILOT STUDY; POWDER; SHELF LIFE; BACTERIAL INFECTION; BACTERIUM; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG IMPLANT; HUMAN; PHYSICIAN;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CALCIUM SULFATE; DIABETIC FOOT; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; DRUG STABILITY; HUMANS; PHYSICIANS; PILOT PROJECTS; POWDERS; TOBRAMYCIN; VANCOMYCIN;

EID: 1542577674     PISSN: 10672516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1067-2516(03)00307-7     Document Type: Article

References (29)

1. Boulton AJ, Vileikyte L. The diabetic foot: the scope of the problem. J Fam Pract 49(suppl):S3-S8, 2000.
2. Armstrong DG. Is diabetic foot care efficacious or cost-effective? Ostomy Wound Manage 47:28-32, 2001.
3. Lipsky BA. Diabetic foot infections. Pathophysiology, diagnosis, and treatment. Int J Dermatol 30:560-562, 1991.
4. Mackey D, Varlet A, Debeaumont D. Antibiotic loaded plaster of Paris pellets: an in vitro study of a possible method of local antibiotic therapy in bone infection. Clin Orthop 167:263-268, 1982.
5. Nelson CL, Evans RP, Blaha JD, Calhoun J, Henry SL, Patzakis MJ. A comparison of gentamicin-impregnated polymethylmethacrylate bead implantation to conventional parenteral antibiotic therapy in infected total hip and knee arthroplasty. Clin Orthop 295:96-101, 1993.
6. Blaha JD, Calhoun JH, Nelson CL, Henry SL, Seligson D, Esterhai JL Jr, Heppenstall RB, Mader J, Evans RP, Wilkins J, Patzakis MJ, Spiegel P. Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis. Clin Orthop 295:8-12, 1993.
7. Roeder B, Van Gils CC, Maling S. Antibiotic beads in the treatment of diabetic pedal osteomyelitis. J Foot Ankle Surg 39:124-130, 2000.
8. Calhoun JH, Klemm K, Anger DM, Mader JT. Use of antibiotic PMMA beads in the ischemic foot. Orthopedics 17:453-457, 1994.
9. Marcinko DE. Gentamycin-impregnated PMMA beads: an introduction and review. J Foot Surg 24:116-121, 1985.
10. Henry SL, Galloway KP. Local antimicrobial therapy for the management of orthopaedic infections. Pharmacokinetic considerations. Clin Pharmacokinet 29:36-45, 1995.
11. Stabile DE, Jacobs AM. Local antibiotic treatment of soft tissue and bone infections of the foot. J Am Podiatr Med Assoc 80:345-353, 1990.
12. Heard GS, Oloff LM, Wolfe DA, Little MD, Prins DD. PMMA bead versus parenteral treatment of Staphylococcus aureus osteomyelitis. J Am Podiatr Med Assoc 87:153-164, 1997.
13. Walenkamp GH, Kleijn LL, de Leeuw M. Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. Acta Orthop Scand 69:518-522, 1998.
14. Kanellakopoulou K, Giamarellos-Bourboulis EJ. Carrier systems for the local delivery of antibiotic in bone infections. Drugs 59:1223-1232, 2000.
15. Wang J, Calhoun JH, Mader JT. The application of bioimplants in the management of chronic osteomyelitis. Orthopedics 25:1247-1252, 2002.
16. Calhoun J, Daum W, Mader JT, Koulisis C, Evans EB. Failure of bipolar hip arthroplasty secondary to retained antibiotic-impregnated polymethylmethacrylate beads. A case report. J Bone Joint Surg 70A:1246-1248, 1988.
17. Bayston R, Milner RD. The sustained release of antimicrobial drugs from bone cement. An appraisal of laboratory investigations and their significance. J Bone Joint Surg 64B:460-464, 1982.
18. Peltier LF. The use of plaster of Paris to fill large defects in bone: a preliminary report. Clin Orthop 382:3-5, 2001.
19. Peltier LF, Jones RH. Treatment of unicameral bone cysts by curettage and packing with plaster-of-Paris pellets. J Bone Joint Surg 60A:820-822, 1978.
20. Peltier LF, Jones RH. The use of plaster of Paris to fill defects in bone. Clin Orthop 21:1, 1961.
21. Gitelis S, Brebach GT. The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J Orthop Surg (Hong Kong) 10:53-60, 2002.
22. Armstrong DG, Findlow AH, Oyibo SO, Boulton AJM. The use of absorbable antibiotic-impregnated calcium sulphate in the management of diabetic foot infections. Diabet Med 18:942-943, 2001.
23. Pienta P, Tang J. ATCC Bacteria and Bacteriophages, Rockville, MD, American Type Culture Collection, 1996.
24. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, 6th ed, pp M2-A6, Wayne, PA, NCCLS, 1997.
25. Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system: the contribution of depth, infection, and vascular disease to the risk of amputation. Diabetes Care 21:855-859, 1998.
26. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 158:158-162, 1998.
27. Boulton AJ, Meneses P, Ennis WJ. Diabetic foot ulcers: a framework for prevention and care. Wound Repair Regen 7:7-16, 1999.
28. Boulton AJ. Lowering the risk of neuropathy, foot ulcers and amputations. Diabet Med 15(suppl):S57-S59, 1998.
29. Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 25:1318-1326, 1997.